The Cooley LLP team specializes in handling high-value transactions in the life sciences, tech, and media industries, displaying a special focus on buy-side M&A and strategic exits. The practice routinely advises domestic and international clients on cross-border stock and cash acquisitions, with the San Diego-based co-head Barbara Borden being an expert in complex joint ventures, restructurings and activism matters. The other co-head, Jamie Leigh, operates out of San Francisco and regularly assists boards and special committees with strategic issues, and Ben Beerle routinely acts on behalf of multinational tech corporations. Steven Tonsfeldt focuses on the software and pharmaceutical spaces from Palo Alto, and the ‘outstanding’ New York-based Bill Roegge is knowledgeable on cross-border private and public M&A.
Testimonials
Collated independently by Legal 500 research team.
‘Cooley is unique in that as a firm, they do a great job to thoroughly understand their client, as well as the situation, before offering advice and counsel.’
‘Bill Roegge is an outstanding lawyer who not only advocated for us as their client, but also is a very decent, respectful person, who is successful without being arrogant or off putting.’
Key clients
- Amryt Pharma
- Carmot Therapeutics
Work highlights
- Advised Horizon Therapeutics on its sale to Amgen for $28.3bn.
- Advised IAA, Inc. on its $7.3bn cross-border stock and cash acquisition by Ritchie Bros.